Acino: Publicity Duties
Thursday 23rd January 2014
After the successful completion of the tender offer of Pharma Strategy Partners for Acino Holding AG (Acino), SIX Exchange Regulation of SIX Swiss Exchange (SIX) has, by decision dated December 23, 2013, exempted Acino from certain disclosure obligations under the Listing Rules of SIX for a limited period of time. A remaining shareholder of Acino has brought an appeal against this decision before the Appeal Body of SIX. With decision of January 22, 2014, the President of the Appeal Body of SIX has granted the appeal suspensive effect. On that basis, Acino will re-assume the publicity duties in accordance with articles 49 et seq. of the Listing Rules until further decision of the Appeal Body of SIX.
